Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SKP235 is a pseudogene, meaning it is a segment of DNA similar to the functional RN7SK gene but not itself transcribed into a functional product or involved in biological activity. The functional RN7SK gene encodes 7SK small nuclear RNA, which is a non-coding RNA regulating transcription elongation by controlling the positive transcription elongation factor b (P-TEFb)[2][3][4][5]. However, pseudogenes like RN7SKP235 are generally considered non-functional; they do not encode a protein, nor do they exhibit the regulatory activities of their parent genes. There is no evidence that RN7SKP235 fulfills any specific biological function, serves as a disease target, or interacts with drugs. The presence of “pseudogene” in its name indicates it is a relic of gene duplication or retrotransposition, not a functional target. As such, it is not considered a therapeutic target, nor is it referenced as a biomarker in disease or pharmacology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 235 (RN7SKP235).